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THEORY
The theory that vitamin A deficiency may bear an important
causal relationship to cancer has had a number of proponents and
the work of certain investigators can be interpreted as supporting
the hypothesis.
One of the first to sponsor the theory was Burrows6' 7 8, who found
that tumor tissue was very low in, or devoid of, vitamin A. This deficiency
also characterized young, fast-growing embryonic tissue, but as the embryo
became older and its rate of growth decreased, the vitamin A content of the
tissue became greater. He concluded that absence of vitamin A and rapid
cellular growth are associated.
Wolbach and Howe44 studied the lesions of vitamin A deficiency in
albino rats and in man and found in various tracts of the body (respiratory,
alimentary and genito-urinary), that the lining of normal cells was replaced
by stratified, keratinizing epithelium. The presence of mitotic figures in
cells of the abnormal epithelium and the response of neighboring connective
tissue and blood-vessels suggested the acquisition of neoplastic properties.
The tissue changes associated with this deficiency were also studied by
Tyson and Smith40, who reviewed the literature to 1928 and called atten-
tion to the fact that up to that time all were in accord in finding epithelial
metaplasia present in the lesions characterizing this condition. Whereas
certain authors regarded the tissue changes as the primary manifestation,
others considered them secondary to infection and other destructive processes.
The formation of gastric carcinoma in albino rats by feeding vitamin A-
deficient diets was claimed by Fujimaki'5, but doubt was cast in an editorial
comment accompanying the report upon the evidence afforded by the micro-
scopic sections. On the other hand Sugiura and Benedict37 reported failure
to produce growth of a tumor in rats after feeding a vitamin A-deficient diet
for protracted periods.
It may be of interest to attempt a reconciliation of the theory that vitamin
A deficiency is a factor contributing to the formation and growth of cancer
with other theories concerning the etiology of this disease'4. Irritation,
trauma and chemical or physical agents, which have been held to be causative
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in the production of cancer, may act by bringing about local destruction of
the vitamin A of the tissue. In this connection it may be pointed out that
the action of tar in the formation of cancer has been explained on the basis
that tar is a fat solvent and, consequently, extracts fat-soluble vitamin A
from the tissue22' 23. Very recently the production in rats and mice of
tumors of connective tissue by subcutaneous injections of 1: 2: 5: 6-diben-
zanthracene in lard, has been reported5, and it is suggested that the injected
material "extracts fat-soluble inhibiting substances from the tissue in contact
with it, and thus promotes carcinogenic action."
It is possible that an hereditary predisposition to cancer, where it exists,
may express itself as an error of metabolism or of nutrition, whereby the
vitamin A of the diet is not properly utilized. The appearance of cancer at
the site of either inflammatory or infected lesions may be explained as due
to loss of vitamin A in the course of the inflammatory process or as a result
of the metabolism of the microorganisms present.
One may also explain certain important findings of Warburg4l in terms
of the vitamin A deficiency theory. He has studied the metabolism of tumor
and normal tissue, finding that among normal tissues the retina of warm-
blooded animals exhibits in vitro the type of metabolism characteristic of
malignant tumor tissue. It is not unlikely that retinal tissue has the same
type of metabolism in vivo, although studies to decide this point indirectly by
an examination of the fluids of the eye, leave the matter undecided2' 43. If
normal retina in vivo has a tumor-like metabolism, one may wonder why it
does not grow like a tumor. The answer may be found in the fact that
retina has been shown to be relatively rich in vitamin A19 46. If, then,
vitamin A has tumor-inhibiting qualities, may not the presence of the vitamin
in the normal retina explain why this tissue is capable of exhibiting the
metabolism of tumor tissue without tumor growth?
These facts suggested that vitamin A of retinal tissue might have
unusually effective tumor-inhibiting qualities, and it seemed possible
to test this hypothesis by feeding a desiccated preparation as a source
of the vitamin to tumor-bearing animals.
Since it was possible that the demonstration of tumor-inhibiting
qualities in the vitamin might depend on quantitative factors solely,
the more concentrated sources, such as the cod-liver oil concentrates
and the provitamin, carotene, were also used.
Previous investigators have studied the effect of varying amounts
of vitamin A upon tumor growth, using for this purpose cod-liver
oil and butter fat"8 ". The former was considered to have no
apparent influence, whereas in experiments in which the latter was
fed so as to constitute 40 per cent of the diet, a diminished rate of
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tumor growth was observed, but the authors suggested that the
effect might be due to a deprivation of other dietary essentials rather
than to the vitamin A.
The present experiments were planned to avoid the effect of
such extraneous factors, and to supply 1,000 times the amount of
vitamin present in an equal quantity of cod-liver oil of good quality.
The use of extremely potent materials may very well be the chief
requisite in an attempt to modify tumor growth by the oral admin-
istration of avitamin. Loss of material may arise from many causes,
such as, (1) failure of absorption from the gastro-intestinal tract
and storage in, or utilization by, body cells; (2) excretion of the
vitamin and, as will be seen later in the case of the provitamin, caro-
tene, (3) failure of conversion of this substance to vitamin A.
Therefore, in addition to testing the effect of retinal tissue, con-
centrated sources of vitamin A were to be fed to tumor-bearing
animals in order to observe the influence of this procedure, if any,
on the growth of experimental cancer.
PLAN OF THE EXPERIMENTS
Mice were implanted with tumor tissue, and a growth curve was
obtained for each tumor. Tumor-bearing animals were fed a num-
ber of different rations, one of which included desiccated retinal
tissue. The maximum amount of vitamin A supplied in this man-
ner did not exceed an amount which, for purposes of comparison,
may be designated as 32 vitamin A units daily. Cod-liver oil con-
centrates were administered as dietary supplements which supplied
as much as 500 vitamin A units. Subsequently, using carotene as a
source it was possible to administer 1,000 units, and by minor
changes of technic a quantity in excess of 2,000. This increasing
of the number of vitamin A units was resorted to in order to ascer-
tain a possibly effective dosage. In order to rule out the effect of
malnutrition on the growth of the tumor", 9, care was taken to
insure at all times the supply of each dietary essential in proper
quantity. Furthermore, the attempt was made to control all other
factors which might conceivably influence tumor growth.
ANIMALS
A small organism was considered desirable for these studies
because less material could be utilized with relatively greater effect.
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Therefore, mice, chiefly albinos, were chosen, the majority of the
animals being raised in the laboratory under controlled conditions
from selected stock.
Each mouse was placed in an individual cage so arranged that
proper feeding could be effected and cleanliness maintained.
The physical conditions under which the mice were held were
kept as uniform as possible, and care was taken to prevent infection.
While an experiment was in progress the particular mice were
handled with strict "isolation technic", that is, not only were they
removed from the other mice, but separate food canisters containing
the bulk diet, separate measuring spoons andotherutensilswereused.
TRANSPLANTATION
As the transplanting of tumor tissue is the simplest, quickest and
most practical method of producing cancer experimentally, it was the
one selected for this investigation.
The Twort mouse carcinoma was used. This tumor is described
by Bashford3, who states that it originated as an alveolar carcinoma
of the mammary gland with small lumina and acini bounded by
columnar cells. Through repeated transplantations the amount of
acinous formation has decreased. Murray"2 states that the tumor is
relatively slow-growing and that it metastasizes only after a period
of 8 weeks. However, the subject of metastases was not within the
scope of this investigation. It seemed reasonable to suppose that
any effect observed on the primary tumor might apply also to
metastases or that, if the primary tumor were inhibited effectively,
metastases might be prevented.
Tumor tissue transplanted to five white mice served as the
original source of supply for all experiments. In order to keep
viable tissue on hand it was necessary to transplant about every 4 to
6 weeks. The technic employed has been described by Lyman25.
The tumors were measured independently by two persons,
usually every day or three times a week, depending on how closely
it was desired to follow the changes of growth. The size of the
tumor mass was determined by measuring its extent from left to
right across the abdomen by applying a millimeter rule. Prelimi-
nary observations showed that the tumor was essentially spheroid
in shape, and it was assumed that when the size of the tumor
changed in one direction, it changed uniformly in all. When the
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tumor was slightly irregular, its diameter was taken to be the pro-,
jection of the tumor on the agreed line of measurement.
The measurements were made and recorded without observing
the amount of the previous entry. It was found that the average
deviation between 480 measurements made by the two observers
was only 0.53 mm. Whenever it was found that measurements
differed by more than an appreciable amount, they were usually
repeated. For the construction of curves expressing growth the
diameter of the tumor was plotted, as ordinate, against time, as
abscissa.
FEEDING
Basal Diets
Unless otherwise indicated all mice were fed the following
basal diet:
Per cent
Casein, washed from milk (Eimer & Amend) ........................ 31
Corn Starch (Corn Products Refining Co., Duryea Brand) ...... 35
Crisco (Procter & Gamble) .................................................. 24
Salt Mixture (Osborne & Mendel*) .................................. ......7
Cod-liver Oil, Norwegian (Harris) .................................. ......3
100
*J. Biol. Chem., 1919, 37, 572.
The dry ingredients of the diet were mixed thoroughly. The
Crisco was melted and the cod-liver oil added to it. This was then
combined with the dry materials with thorough mixing.
Dried yeast powder (Northwestern Yeast Co.) in amounts vary-
ing with the weight of the mouse, was added daily to this and all
other diets.
Water was allowed ad lib.
The above diet is substantially that described and used by Beard4
and found to be adequate for the nutrition of albino mice. It was
assumed to be adequate also for all the mice used in these experi-
ments. Breeding mice received, in addition, lettuce three times per
week, and lactating mice and young mice for one week after weaning
had access to whole-milk powder dissolved in water.
In experiments in which carotene was fed, peanut oil replaced
Crisco in the basal diet and the percentage was reduced. This reduc-
tion was necessary because peanut oil is not solid at room tempera-
ture and a higher percentage would render the diet too greasy.
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The percentages, when peanut oil was substituted, were:
Percent
Casein ......... ........................ 31
Corn Starch .............. ................... 39
Peanut Oil ............ ..................... 20
Salt Mixture ............... .................. 7
Cod-liver Oil ............... .................. 3
100
In other respects the basal diet was unchanged.
Sources of Vitamin A
In order to compare the potency of the various substances admin-
istered, the dosage is expressed in vitamin A units. The unit is
determined by assay and is, in general, the minimum amount of the
substance per day, which, when fed under specified conditions, will
cure the symptoms of vitamin A deficiency in a rat. The subject of
assay is discussed in a recent report35. Notice concerning the adop-
tion of the international unit was received after the experiments were
begun.
In the following table the number of vitamin A units is not
intended to represent the exact equivalent of the dosages admin-
istered, but to serve merely as a convenient basis of comparison.
The substances are arranged into four groups in the order in which
they are discussed. It will be noted that the maximum number of
vitamin A units supplied increases in each succeeding group.
Dose ApproximateNumber
Name of Substance milligrams of Vitamin A Units
I. Desiccated Retinal Tissue .......................... 1,600 32
Desiccated Retinal Tissue .......................... 1,300 26
II. Cod-liver Oil Concentrate(Health Products
Corp.) ................... ................ 50 500
Cod-liver Oil-i 0 X (Health Products
Corp.) ................. .................. 50250
Cod-liver Oil (Harris) .............................. 50 25
III. Carotene (British Drug Houses, Ltd.) ...... 2.0 1,000
Carotene (British Drug Houses, Ltd.) ...... 1.0 500
Carotene (British Drug Houses, Ltd.) ...... 0.1 50
IV. Carotene (British Drug Houses, Ltd.) ...... 4.6 2,300
Carotene (British Drug Houses, Ltd.) ...... 4.4 2,200
Carotene (British Drug Houses, Ltd.) ...... 4.2 2,100RELATION OF VITAMIN A TO CANCER
The desiccated retinal tissue was prepared in the manner
described by Yudkin, Kriss and Smith46. Twenty-six hundred pigs'
eyes were dissected and from the material thus obtained 60 gm. of
dried tissue were prepared.
A diet was prepared to supply the maximum amount of retina
which it seemed permissible to give without endangering the nutri-
tion of the animal. The tissue was used to replace entirely the
starch and fat of the diet. Furthermore, since considerable vitamin
A was supplied in this way, the cod-liver oil was also replaced by
retinal tissue and provision made to supply the antirachitic vitamin D
by the daily addition of a small drop (10 mg.) of viosterol. The
substitution of retina for the fat of the diet which may supply cer-
tain dietary essentials*24, is justified by the fact that 20 per cent of
the dried retina is extractable by ether46.
The diet was, as follows:
Per cent
Retinal Tissue ..................... ............. 62
Casein ........... ....................... 31
Salt Mixture .................. ................ 7
100
The average daily consumption of this diet by two animals was
2.5 and 2.1 gm., or 1.6 and 1.3 gm. of retinal tissue, equivalent to
approximately 32 and 26 vitamin A units, respectively.
In the cod-liver oil experiments the cod-liver oil concentrate,
cod-liver oil-10 X and cod-liver oil (Harris) were measured into
the food-cups with a hypodermic syringe; five drops, or about
50 mg. of each substance were fed per day.
It was found that the mice did not eat the oil products readily
and, consequently, it was necessary to devise a method of "forced
feeding". Since the period of greatest eating activity of the mouse
is during the night, the vitamin supplements were offered about
4 P. M. The oil for each mouse was placed on as small an amount
of the basal diet as would conveniently soak it up and the saturated
food was offered first, the daily allowance of yeast being placed in
the cup at the same time. The cups were inspected at 10 P. M.,
2 A. M., and 5 A. M. and as soon as one was found to be empty, it
was replaced by another containing basal diet.
Fifty milligrams of a cod-liver oil product were considered to
* An objection to some of the evidence that fat is a dietary essential has recently
been raised by Hume and Smith20.
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be the maximum amount which could be added to the basal diet
without too greatly increasing its caloric value. This amount of
oil increased the calories of the daily ration by approximately 5 per
cent, which is within the daily variation of the voluntary caloric
intake of animals". By adding the 50 mg. to the daily ration, 500,
250, or 25 vitamin A units were supplied by the cod-liver oil con-
centrate, cod-liver oil-10 X or cod-liver oil, respectively.
To supply more vitamin A a more potent source was necessary,
and this was effected in the carotene experiments.
Carotene is a crystalline hydrocarbon, deep orange, almost red
in color, having the formula C40 H56. It is extractable from
carrots, lettuce, spinach and other plants, carrots being the source of
the material used in these experiments.
Steenbock, in 1919, suggested that carotene might be related to
vitamin A36, and, indeed, it has since been demonstrated that the pig-
ment is the precursor of the vitamin, being converted thereto in the
9016, 21, 26-31 animal organism',
As the substance is readily oxidized when exposed to air, certain
precautions were necessary in its handling and in making up the
daily food ration.
Since it was impractical to attempt to weigh out the small quan-
tity of crystalline carotene in the daily ration, it was necessary to
dissolve this material in the fat of the basal diet and apportion it
from the solution. Consequently, an oil, fluid at room temperature,
was desirable as the fat solvent and, as already mentioned, peanut
oil was chosen. It is probable also that the carotene is better
absorbed from solution in an oil than if mixed directly into the food
in crystalline form. Moreover, it was necessary to use an inter-
mediate solvent to effect the concentration desired, for otherwise the
pigment dissolved very slowly and incompletely at temperatures
below 450 and it was not desirable to heat higher than this for fear
of losses by oxidation.
For this purpose cyclohexane, a hydrocarbon, was chosen. The
carotene was dissolved in a convenient amount of this liquid, the
solution was added to the proper quantity ofpeanut oil and the cyclo-
hexane driven off by vacuum distillation.
This solution of carotene in peanut oil was made up (a week's
supply at a time), and kept on ice in a flask under nitrogen and pro-
tected from light.
For these experiments the solution was made so that 200 mg. of
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peanut oil contained 1 mg. of carotene. In the formula used
in preparing the food for the basal diet of these experiments, one
gram of food contained 1 mg. of carotene. By varying the amount
of this specially prepared food put into the cages, groups of mice
were fed 1,000, 500, or 50 vitamin A units, respectively. In each
case after the desired amount of this food was eaten, basal diet was
then offered.
Later, in confirmatory carotene experiments the animals were
given all the food containing carotene which they would eat without
restriction, and to increase still further the consumption of carotene,
the foodwas made up exactly asdescribed, excepting that the peanut-
oil solution was supersaturated by doubling the concentration of the
carotene.
In this manner three mice received a daily average of 2.3, 2.2
and 2.1 gm. of food which contained 4.6, 4.4 and4.2 mg. ofcarotene,
supplying 2,300, 2,200 and 2,100 v'itamin A units, respectively.
Many mice were implanted with tumor tissue throughout the
course of the study for purposes of insuring a supply of this material.
Not all of such implants were studied, but a number, referred to
later under the subject of tumor growth, afforded an opportunity
to compare tumors of different strains of mice.
With two exceptions no animals were used for implantation
before they were 10 to 12 weeks old, at which time it was believed
that they were sexually mature. It was also desirable not to allow
the animals to become too old, as senility might introduce other
variables. Therefore, no animals over 5 months at time of implant-
ation were selected. Careful observation of the behavior and gen-
eral nutrition of the mouse, including a study of weight and food
intake, was the routine before an animal was selected for an experi-
ment. The animals were kept under observation for varying peri-
ods of time, usually until moribund, comprising a period of
approximately 2 or 3 months after implantation.
In addition to the data oftumor measurements, two other records
were kept, one of body weight, the animals being weighed twice
weekly, and the other of food intake.
Cowgill1' has shown that in the absence of disease or factors
causing loss of appetite, as unpalatable food, the daily food intake
is primarily determined by the energy requirements. The practical
significance of these data is discussed later in respect to the nutrition
and condition of the mice.
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RESULTS
It was necessary to weigh a number of considerations before
determining the criteria for judging the effectiveness of the sub-
stances administered. Because of the high cost of the carotene and
the time required for preparing large quantities of retinal tissue,
an investigation employing many animals was impractical. Deter-
mination of a satisfactory procedure was assisted by the early obser-
vation that growth curves of established tumors followed, except
for minor variations, a straight line and, consequently, one criterion
for judging deviations from the usual growth was the extent to
which a curve departed from the straight line.
Another problem was presented by a characteristic phenomenon
known as "regression". It is common experience in cancer research
that certain implants will grow for a short time, and then completely
disappear. The growth curves of a number of such tumors were
studied and found to be more or less typical, and all tumors whose
growth curves resembled this type were classed as regressions.
These tumors included those of mice receiving the vitamin sup-
plements, but since the disappearance of such tumors was evidently
due to factors beyond the control of the experimenter, no cognizance
was made of them in drawing conclusions as to the efficacy of the
feeding of the vitamin. To have determined whether the vitamin
influenced any such regressions, which was a possibility, was not
feasible. The criteria, then, for judging a definite effect exerted
by the substances tested were: (1) that the growth curve depart
from a straight line characteristic of normal growth; (2) that it be
unlike the regression type of curve; and (3) that such effects be
confirmed by a reasonable number of repetitions.
It was essential that the nutrition of the animal be maintained,
for it has been shown that retardation of tumor growth can be caused
by malnutrition"2 9. Evidence will be presented to show that such
an extraneous factor probably did not mask the results observed in
these experiments.
CRITERIA OF NORMAL TUMOR GROWTH AND DEVIATIONS
The first tumor-growth curves illustrated (fig. 1) are those of
13 mice which were used to insure a supply of tumor tissue. These
mice received the basal diet and apparently all were well nourished.
The neoplastic growth was considered to be normal, that is, the type
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FIG. 1. GROWTH CURVES OF 13 TUMORS EXHIBITING NORMAL GROWTH. (Tissue
implanted to insure supply; all mice fed basal diet only.)
This straight line type of growth-curve was considered to be the criterion of normal
tumor growth. The same type of growth-curve was also exhibited by tumors of
12 other mice receiving basal diet. These were control animals, whose curves are
illustrated with the report of the individual experiment.YALE JOURNAL OF BIOLOGY AND MEDICINE
to be expected under usual conditions. The implants of 13 other
mice receiving basal diet were also found, with one exception, to be
discussed later, to exhibit the same characteristics. These mice were
control animals, whose tumor-growth curves are shown in connec-
tion with the description of the individual experiments.
The character of tumor growth was essentially the same among
mice of different strains.
Twenty-five tumors were classed as regressions. Nine were in
mice implanted to insure a supply of the tumor tissue, all of which
received basal diet, and the others were in experimental animals.
The growth curves of all these implants are shown in fig. 2. Most
of these tumors disappeared, or showed definite signs of disappear-
ing, within about 3 weeks. In all cases the curve is more or less
typical. It exhibits usually a sharp rise. In a few cases the maxi-
mum height is maintained for a short period; in the majority, it is
not. The decline is usually rather rapid, so that in most instances
the curve resembles an inverted V.* In the absence of any indica-
tions to the contrary, a prompt disappearance of the tumor or the
inverted V type of curve was taken as the criterion of regression.
Certain implants showed no signs of growth and, as in the case
of regressions, such failure to grow was not interpreted as due to the
previous administration of vitamin supplements.
Of 102 implantations studied, 25 regressed and 26 failed to
grow. Under no circumstances were mice used for reimplantation.
Before reporting the results of the individual experiments a
number of minor variations in the growth curves may be discussed
briefly. A sharp dip and recovery in a curve may be caused by a
temporary loss of tumor substance resulting from an ulceration
which subsequently healed (BF-17, fig. 3), but when such occurred
within a significant experimental period the animal was exduded
from consideration in evaluating results. On the other hand, if an
ulceration occurred after the character of the tumor-growth curve
appeared to be definitely determined, the data obtained were con-
sidered of experimental value.
A number of curves show a plateau at their origin, which corre-
sponds to a latent period before the tumor implant begins to grow
to a measurable degree (BF-12, fig. 1;. 13-C, fig. 8). In such
* In a number of instances the mouse was sacrificed before the tumor disappeared
completely, which explains why some curves do not return to the base line.
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FIG. 2. GROWTH CURVES OF 25 TUMORS WHICH REGRESSED.
The phenomenon of regression is discussed in the text. It should be noted that the
inverted V type of curve predominates. Tumors 19-A, 21-A, 22-A, 24-A, 36-A,
38-A, 27-B, and 12-C were in control mice receiving basal diet only. All other
tumors in the upper groups were in mice receiving vitamin supplements.
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cases a small nodule of about 3 to 5 mm. diameter appears, due to
the deposited piece of tissue plus what are probably local tissue
changes. If the first measurement is made within a few days after
implantation, and the amount plotted, there will be a relatively steep
rise from the zero point of the curve to the beginning of the plateau.
RETINA EXPERIMENTS
The tumors of the two animals receiving 1,600 and 1,300 mg.
of the dried tissue, supplying 32 and 26 vitamin A units, respec-
tively, will be considered first. The feeding of this substance was
begun 12 days after implantation and continued for a period of
15 days.
No Inhibition of Tumor Growth
Both neoplasms continued to grow without any apparent change
in rate subsequent to the administration of the vitamin supplements,
as indicated by the fact that both growth curves are unaltered in
direction and continue as straight lines (fig. 3).
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FIG. 3. GROWTH CURVES OF 2 TUMORS. (Retina Experiments.)
The feeding of retina was started 12 days after implantation and continued for
15 days. Both curves exhibit normal growth. Hence, it was concluded that desic-
cated retinal tissue, under the conditions of the experiment, had no effect on the
growth of the tumor. In BF-17 ulceration occurred at the point marked with
the asterisk.
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It was conduded that the tumor growth was unaffected by feed-
ing the retinal tissue over the stated period.
COD-LIVER OIL EXPERIMENTS
This was the first of a series of experiments using potent sources
of the vitamin. Since a possibly effective dosage was unknown, it
was desirable to obtain, if possible, an early physiological effect,
which might be accomplished by feeding the vitamin supplements
early in respect to time of implantation. The feeding of some
animals was started on the day of implantation and of others, a
week before. If the vitamin had tumor-inhibiting qualities it was
thus given a better opportunitytoshowthemthaniffedsubsequently.
Tumor Growth not Retarded
All tumors in this experiment, which included those of 13 ani-
mals fed up to 500 vitamin A units in the form of cod-liver oil
products and those of 4 mice which were used as controls and which
received basal diet, increased constantly in size. The growth
curves, illustrated in figs. 4and 5, are essentially straight lines. The
administration of the vitamin supplements to these animals was
without apparent effect on the growth of the cancer.
Ten implants in this experiment regressed. Their growth
curves are shown in fig. 2 with other curves of regressing tumors.
CAROTENE EXPERIMENTS
The procedure of feeding the vitamin supplements early in
relation to time of implanting was also followed in the initial caro-
tene experiments, the only difference being that the mice receiving
the carotene before implantation, received it 12 days rather than a
week before, in order to increase still further the chances of the
vitamin showing a possible inhibiting effect. As many as 1,000
vitamin A units were fed in these experiments, whereas in the cod-
liver oil experiments the maximum dosage was 500 vitamin A units.
The growth of 9 tumors will be considered.
Tumor Growth Unaffected (Smaller Dosages)
It was observed that the diameters of the cancers of all mice
receiving up to 500 vitamin A units ofcarotene, as well as the control
mice receiving basal diet, constantly increased in size, the growth
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FIG. 4. GROWTH CURVES OF 17 TUMORS. (Cod-liver Oil Experiments)
All curves show normal growth. Hence, it was concluded that cod-liver oil, as
administered, had no effect on the growth of the tumor. (Continued on fig. 5.)
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FIG. 5. GROWTH CURVES OF 17 TUMORS. (Cod-liver Oil Experiments)
(Continuation of fig. 4.)
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curves being characteristic of normal tumor growth (fig. 7), from
which it was concluded that these supplements of vitamin A were
without effect, thus confirming the results of the experiments pre-
viously described, in which cod-liver oil products in comparable
quantities were administered. In the case of the mouse receiving
1,000 vitamin A units of carotene, the feeding of which was started
on the day of implantation, the same type of tumor growth, as indi-
cated by the curve (15-B, fig. 7), was observed.
Retarded Tumor Growth (Larger Dosages)
However, in the case of both mice (2-B and 3-B) receiving
1,000 vitamin A units of carotene for the maximum period, that is,
from 12 days prior to implantation of the tumor, certain changes in
the tumor growth were noted, fig. 6.
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FIG. 6. GROWTH CURVES OF 9 TUMORS. (First Carotene Experiments)
Curves 2-B and 3-B are discussed in the text. All other curves in the first carotene
experiments exhibited normal growth. (Continued on fig. 7.)
Tumor 3-B, whose curve is the lower one on the page, will be
considered first. The growth ofthis neoplasm was very successfully
inhibited. At no time did its diameter exceed 10 mm., whereas the
continuously growing tumor may reach a diameter of 30 mm. or
more. On the 92nd day after implantation the tumor had almost
disappeared. At this time the mouse was sacrificed in order to
obtain microscopic sections of the tumor.
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FIG. 7. GROWTH CURVES OF 9 TUMORS. (First Carotene Experiments)
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It will be seen that this curve does not exhibit the straight line
characteristic of normal growth. In fact it resembles the arc of a
circle. It is low and flat, and at its distal end points downward
toward the base line.
One must decide whether or not this curve is similar to those
of the regressing implant (fig. 2). If so, this effect can not be
considered as being due to the carotene. The curve does not
resemble the inverted V, characteristic of most regressions. The
time element is another point of difference. The tumor which was
the slowest to regress (36-A, fig. 2), first showed definite signs of
receding 50 days after implantation, while with tumor 3-B, such
signs did not appear until 85 days after implantation. Thus, the
tumor of mouse 3-B was not classed as a regression.
Microscopic sections of the tumor failed to reveal characteristics
which would differentiate it from that of the regressing neoplasm.
As noted on the curve the dosage of carotene was increased* at
one point and later stopped entirely. These procedures were appar-
ently without influence on the direction of the curve.
It will be seen that tumor 2-B (curve at top of fig. 6) also
exhibited certain peculiarities. For a period of about 15 days
(indicated on the curve by the letters AB) its growth was practically
at a standstill. Beyond this period, however, the tumor again
increased in size. It seemed possible in the case of this mouse that
the carotene might be less effective than in mouse 3-B, because the
body weight of mouse 2-B averaged 3 gm. more than that of 3-B
throughout the greater part of the experiment and, consequently,
per unit weight 2-B received less carotene. Thereupon the dosage
was increased for this mouse and the growth rate of the tumor again
decreased, as indicated by the gradual flattening of the curve which
became a plateau at CD. Later, the tumor again increased in size,**
* 4.5 mg. of crystalline carotene, equivalent to 2,250 vitamin A units, in addi-
tion to the regular daily allowance, were mixed into the food for a period of 15
days.
** At a time corresponding to point D on the curve, a gradual reduction of the
amount of carotene was begun and the feeding of the pigment was entirely discon-
tinued after 5 days in order to ascertain whether the rate of growth would increase.
This actually happened, as the change in direction of the curve beyond D indicates,
but as the mouse had to be sacrificed within a few days after this change occurred,
the period of increased rate of growth was so short that the result could not be
considered a substantiation.
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after which the mouse was sacrificed for microscopic study of the
tumor. This study revealed no unusual features. Since this tumor
did not disappear, it cannot be classed as a regression, and this applies
likewise to all subsequent instances where tumors exhibited periods
of retarded growth.
In the above experiment the extra carotene was fed in the form
of the pure product, mixed into the food. An average of 7.4 mg.
or 3,700 vitamin A units of additional carotene was given in this
way for 42 days.
In this experiment S tumors regressed. Their growth curves
are shown in fig. 2.
CONFIRMATORY CAROTENE EXPERIMENTS
If the previously described responses in tumor growth could be
reproduced at will in confirmatory experiments, it seemed possible
that the observed effect might be due to the carotene. Accordingly,
it was decided to begin feeding the carotene at a convenient time after
implantation, when it seemed that the tumor was established and
would not regress.
Ten animals were divided between two experiments performed
at different times, thus constituting two distinct repetitions. The
first experiment included two mice, namely, 14-C receiving carotene,
and one control animal, 13-C, receiving basal diet. Both received
tumor implants on the same day, as was customary.
Periods of Retarded Tumor Growth
Mouse 14-C was started on the feeding of the carotene 5 days
after implantation and was allowed to consume the carotene for 54
days, during which time it ate an average of 4.6 mg. of the pigment
daily, equivalent to 2,300 vitamin A units. The tumor grew very
slowly; on the fifty-ninth dayafterimplantationitsdiameterwas 12.5
mm., while in the control mouse the diameter of the tumor was 22.5
mm. Tumor 14-C exhibited several periods when growth was
practically stationary, two of which are indicated in its curve by
plateaus, AB and CD. The feeding of the carotene was sub-
sequently discontinued in order to observe whether the rate of
growth would become accelerated. This occurred, as indicated by
the difference in direction between MN, the slope of the curve
143YALE JOURNAL OF BIOLOGY AND MEDICINE
during the feeding of the carotene, and OP, the slope during the
subsequent period.
The tumor of the control mouse, 13-C, after a slightly prolonged
latent period, began to grow and exhibited the curve of normal
growth.
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FIG. 8. GROWTH CURVES OF 10 TUMORS. (Confirmatory Carotene Experiments:
First Group of 2 Mice)
The characteristics of curve 14-C are discussed in the text. The tumor of the control
mouse 13-C exhibited normal growth. (Continued on fig. 9.)
The fact that during certain periods the diameter of tumor 14-C
did not appreciably increase in size, and that an increased rate of
growth resulted after discontinuing the feeding of the carotene,
seemed to confirm the earlier findings, namely, that this substance
was effective in retarding the growth of the cancer.
In the second of these confirmatory experiments, 8 mice were
used, 2 of which received carotene, 6 serving as controls. The
tumor-growth curve of mouse 32-C, one of those receiving carotene,
and the curves of all control animals are shown in fig. 9. The
growth of the tumor of the other mouse receiving the carotene is
discussed separately in the following section.
Mouse 32-C received a daily average of 4.4 mg. or 2,200 vita-
min A units of carotene, the feeding of which was started 10 days
after implantation of the tumor. Beginning about 14 days after the
feeding of the carotene was instituted and for a period of about 24
days, the tumor did not appreciably increase in size, as indicated
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FIG. 9. GROWTH CURVES OF 10 TUMORS. (Confirmatory Carotene Experiments.
Second Group of 8 Mice)
Curve 32-C is discussed in the-text. The tumors of all control mice exhibited
normal growth, except that of mouse 4-C, which is also discussed in the text.
(Continuation of fig. 8.)
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by the plateau of the curve. This result was considered to be
confirmatory.
The tumors of the control mice receiving basal diet grew nor-
mally, with the exception of that illustrated by curve 4-C, which
exhibited a period of restrained growth, despite the fact that this
mouse had not received carotene. This was the only tumor among
26 mice receiving basal diet which exhibited an extended period of
inhibited growth.
The frequency with which irregularities of tumor growth are
ordinarily observed among control animals in cancer research and the
consequent difficulties of interpretation have been commented upon
by Wood45. The fact that such inconsistencies occurred so infre-
quently in this investigation may possibly be due to the control of
many variables, including the nutrition of the animal and infection.
In support of this, the uniformity of results among animals receiving
the vitamin supplements is also striking. There were no scattered
instances of retarded growth. The tumors grew normally in 21
mice receiving vitamin supplements and only in the tumors of
4 animals, 2-B, 3-B, 14-C and 32-C, receiving maximal dosages
was inhibited growth observed.
The curve of one additional implant which regressed is shown
with those of other regressing tumors in fig. 2.
No Retardation and a Possible Explanation
It is of interest to consider the tumor of the other animal receiv-
ing carotene, mouse 11-C. In view of the results previously
described, one might expect that in this animal, which received a
daily average of 4.2 mg. or 2,100 vitamin A units of carotene begin-
ning on the tenth day after implanting, the cancer would have
responded by a period of inhibited growth. However, this was not
the case, as reference to the growth curve, fig. 10, will reveal.
There are no plateaus. The curve is not flat. Instead, it rises
rapidly as in the curve of normal tumor growth. Why was there
an absence of response in the case of this mouse? A possible expla-
nation was that the carotene in this instance may have failed of con-
version to the vitamin.
It has been demonstrated that carotene is converted to the vita-
min chieflyin the liver 27, 30, 31. Olcott and McCann34 have reported
the conversion in vitro. These authors used an extract of rat liver
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and concluded that the transformation was due to an enzyme, which
they named carotenase, but it should be pointed out that Ahmad'
has failed to demonstrate the conversion of carotene in vitro and that
the conclusions of Olcott and McCann are based on spectroscopic
evidence only. The possibility that the liver of mouse 1 -C lacked
carotenase was studied in this laboratory by Olcott, who reported
that the enzyme carotenase, while present in the liver of control
mice, was actually lacking in that of mouse 11-C.
Feeding Started Cte 10 Days After Sty-tedno 20 rnm.
Implantation dia mete
Average daily dosage:
2100 vitamin A
units
IIC 20 days
FIG. 10. GROWTH CURVES OF 10 TUMORS. (Confirmatory Carotene Experiments.
Second Group of 8 Mice)
Although mouse 1I-C received an average of 2,100 vitamin A units of carotene daily,
its tumor exhibited normal growth. An investigation disclosed the fact that the
liver lacked the enzyme, carotenase, which converts carotene to vitamin A. (Con-
tinuation of fig. 9.)
This may explain why the growth curve of the tumor of this
mouse did not show intervals of inhibited growth, as did those of
2-B, 3-B, 14-C and 32-C.
The demonstration of this fact was the result of a circumstance
occurring late in the course of this investigation and, consequently,
the desirability of such tests was not appreciated earlier. It would
have been particularly advantageous to find the enzyme present in
the livers of the mice receiving carotene, whose tumors were
retarded. It would also be of interest to determine how frequently
among a group of mice taken at random this enzyme is lacking.
NUTRITION AND CONDITION OF ANIMALS
In interpreting the results described it is essential to eliminate
other factors which might influence tumor growth.
The criteria by which one may judge the condition of experi-
mental mice include the general health of the colony, appearance
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and activity of the animals during life, changes in body weight, food
intake data, and findings at autopsy..
The experiments were not marred by epidemics, nor was a valu-
able animal lost during an experiment. Skin lesions, suggestive of
pellagra, developed in the case of two mice (7-A and 32-A) of the
cod-liver oil experiments and were considered as being due possibly
to a toxic effect of the oil concentrate33. The dried yeast of the diet
of these animals was replaced by yeast vitamin concentrate (Harris)
for 22 and 12 days, respectively, during which the skin lesions
cleared. The growth of the tumor was apparently unaffected.
The administration of the larger dosages of carotene appeared to
be innocuous. There was nothing, so far as the general appearance
of the animal was concerned, to warrant the conclusion that retarda-
tion of the tumor of the mice receiving the larger dosages of carotene
was due to a detrimental, systemic effect. These observations con-
cerning the apparent harmlessness of the carotene are supported by
the findings of Wells and Hedenburg42, who injected as much as
200 mg. in 5 cc. of olive oil intraperitoneally into guinea pigs with-
out harmful effects.
It is surprising that the mice receiving the maximal amounts of
the pigment did not show a yellow coloration of the skin, in view
of reports in the literature of such a condition (carotinemia) in
man17, 18* This clinical entity is apparently not of the nature of a
toxemia. It results from the ingestion of foods such as carrots, con-
taining the pigment. Moreover, it is pertinent to state that the
amount of carotene thus supplied to man is relatively much less than
that which was fed to certain mice in this study. It may also be
said that there was not found grossly at autopsy any unusual colora-
tion of the organs of any animals receiving carotene. A consider-
able amount of carotene appeared to be lost through the gastro-
intestinal tract, as judged by the orange-red coloration of the feces
of certain animals. This confirms a similar observation made by
Moore3".
Autopsies were performed on nearly all animals. In general,
there were no findings of note which could not have been explained
as due to pressure of the tumor. A cyst was found in the liver of
mouse 34-A, one of the animals which received cod-liver oil supple-
ments, but this finding was not duplicated.
Records of body weight were kept, but it was found that these
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data per se were not of great assistance, because the weight of the
tumor masked the actual weight of the animal.
Beard4 studied the nutrition of the albino mouse and showed
that a satisfactory way of making allowance for the difference in
weight among mice is to relate the energy derived from the food
consumed, expressed as calories, to the two-thirds power of the
body weight. In this way he computed a constant calories, which, weight2/3 wih
for his animals, ranged from 1.4 to 1.8.
In order to obtain figures for comparison with Beard's results,
6 white mice without tumors were studied at the time the carotene
experiments ,were performed. It was found that their constants
were either 1.2 or 1.3, which is lower than those of Beard's mice
and may be accounted for by a difference in caging. Comparison
of the constants of the mice having tumors with those of the mice
without tumors, showed the values for the first group, which range
from 0.9 to 1.5 (averaging 1.16), are lower than those of the con-
trols (averaging 1.25). One may expect that the tumor accounted
in part, if not entirely, for the difference. It was observed, for
example, that as the tumor increased in size, the animal became less
active and, consequently, its energy requirements became less. The
tumor may have affected the food intake in other ways, mechanical
or toxic. On the other hand, this lowering of the energy require-
ment of the tumor-bearing animal, might be offset to some extent by
the high glycolytic metabolism of the individual tumor cells41.
It was found that the energy requirements of the mice whose
tumors were inhibited compared favorably with those of other
tumor-bearing mice; the constants for mice 2-B, 3-B, 14-C and
32-C, whose tumors exhibited restraint of growth, are 1.0, 1.2, 1.0
and 1.1, respectively, which compare favorably with the range of
constants for the entire group of tumor-bearing mice (0.9 to 1.5).
Since in the latter all tumors grew without retardation, it is obvious
that food intake and energy requirements were sufficient to permit
such growth. Consequently, the deduction may bewarranted, so far
as these figures are concerned, that the food intake and energy
requirements ofthe mice whose tumors were retarded, were sufficient
to permit unretarded tumor growth, and that the retardation which
was observed must have been due to some other factor, presumably
to the maximal dosages of vitamin A administered.
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This information together with that pertaining to the general
appearance and condition of those animals whose tumors were
retarded, might warrant the belief that the action of the vitamin is
without harm to the organism as a whole and, consequently, is
specific for the cancer cell.
DISCUSSION
The results of this study indicate that the possible inhibition of
tumor growth by the administration of vitamin A.may resolve itself
into a quantitative problem, in which there are two major considera-
tions, (1) the feeding of large dosages of vitamin A and (2) the
discovery of more efficient methods of administering the vitamin.
It is certain that no ordinary amounts of vitamin A, such as may
be supplied by the usual ration, will affect transplanted neoplasms
of mice. In this respect the work confirms the findings of Sugiura
and Benedict"9, who reported failure to influence tumor growth in
rats by feeding a diet containing 10 per cent of cod-liver oil.
Concerning an evaluation of the effect of the larger dosages
administered, one must proceed with caution. It was observed that
among the mice to which vitamin supplements were fed, inhibition of
tumor growth occurred in those animals receiving maximal dosages
only. In other respects also the results were quite consistent. Nor-
mal tumor growth was observed in all control and other mice
receiving basal diet with a single exception. Nevertheless, the inter-
pretation of certain findings is extremely difficult. No differences
between inhibited and other tumors were revealed by histological
study. In one instance, stopping the administration of vitamin sup-
plements accelerated the rate of growth; in another instance no
change was observed. This latter finding applied to a tumor which
gave definite evidence of disappearing. It is possible that control
of growth had been so successful in this case that the subsequent
variation of dosage was without effect.
The different degrees of inhibition observed ranged from the
definite control of the tumor just referred to, to a single period of
inhibited growth lasting for 24 days, which was followed by a
definite increase in size. It would be extremely interesting, were
it possible, to demonstrate that such differences are due to variations
in the capacity of the animal to utilize the carotene administered.
Limitations in this respect were observed. In the first place, loss of
carotene through the gastro-intestinal tract was evidenced by the
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orange-red coloration of the feces. Ahd, secondly, in the instance
of one mouse whose tumor grew normally despite the administration
of large amounts of vitamin A, it was apparently demonstrated that
the enzyme, carotenase, was absent from the liver of the animal,
that conversion of the carotene to vitamin A was undoubtedly inter-
fered with and, consequently, the animal was deficient in its ability
to utilize this pigment.
One may conclude, therefore, that it is not carotene per se but
vitamin A per se that is the effective agent and, unless the carotene
is converted to the vitamin, no inhibition of tumor growth occurs.
Assuming, therefore, that vitamin A may effectively inhibit tumor
growth if administered in a still more efficient manner, the question
may be asked, "How can this be done?"
Until very recently carotene has been the most concentrated
source of vitamin A obtainable. The plan considered was to con-
tinue the feeding of the carotene and at the same time to attempt
to supply the enzyme exogenously as a water extract of homologous
liver by intraperitoneal injection. Thus the mouse might be
assisted in converting to the vitamin the provitamin (carotene)
administered.
While this was under consideration there appeared the announce-
ment that a new vitamin A concentrate had been produced"3. Con-
sequently, this new substance would afford an opportunity to admin-
ister a large quantity of vitamin A without imposing upon the animal
the task of producing it. Therefore, the next logical step, based
on the general findings of this investigation, would be to administer
this new preparation of the vitamin to tumor-bearing mice, using
dosages up to the order of magnitude suggested by this study.
CONCLUSIONS
The study of the effect of varying dosages of vitamin A from
various sources on the growth of tumors of mice under controlled
conditions showed that the tumor implants of mice were not affected
by those amounts of vitamin A contained in the usual diet, supple-
mented by as much as 500 units of vitamin A. On the other hand,
when maximal dosages (1,000 or more vitamin A units) of the
provitamin, carotene, were administered, varying degrees of inhibi-
tion of tumor growth were observed.
The utilization of the carotene was limited by a number of fac-152 YALE JOURNAL OF BIOLOGY AND MEDICINE
tors, including apparent failure on the part of the animal to convert
the carotene to vitamin A, this incompetency being due to the absence
from its liver of the enzyme, carotenase. The problem of inhibit-
ing tumor growth by means of vitamin A becomes one of deter-
mining whether more efficient methods of administration can be
devised. Two possible procedures are worthy of trial: (1) the
feeding of carotene plus the injection of a source of the enzyme,
carotenase; (2) the feeding of new preparations of vitamin A
concentrate.
The administration of the maximal dosages of vitamin A
appeared to be without a harmful effect upon the animals. This
suggests that the inhibited growth of the tumor is the result of a
specific action of the vitamin A upon the cancer cell.
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